Malady Kyle โ EVP and Group CEO-VZ Business
Shares
132
Price
$13.16
Total Value
$1,738.07
Nearby Earnings
Jul 20, 2026
EPS:Est: 1.27
Revenue:Est: $35.48B
Jul 21, 2026
EPS:Est: 1.27
Revenue:Est: $35.48B
Jul 24, 2026
EPS:1.30 (est: 1.27)+2.4%
Revenue:$34.25B (est: $35.16B)-2.6%
Transaction Details
| Insider | Malady Kyle |
|---|---|
| Title | EVP and Group CEO-VZ Business |
| Transaction Date | Jul 30, 2026 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Phantom Stock (unitized) |
| Derivative | Yes |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Deferred Compensation Plan |
| Filing Date | Aug 3, 2026 |
| Shares Purchased | 132 |
| Price per Share | $13.16 |
| Total Value | $1,738.07 |
| Shares Owned After | 417,827 |
| Derivative | Derivative |
| Accession Number | 0001760581-26-000040 |
| Document | View SEC Filing |